These types of carryover must not lead to the carryover of degradants or microbial contamination that could adversely change the established API impurity profile.(biotech) refers to the usage of cells or organisms which were produced or modified by recombinant DNA, hybridoma, or other technologies to produce APIs. The APIs made by biotechnological